IASLC - Immunotherapy In Driver - Positive NSCLC

In this episode of Lung Cancer Considered, host Dr. Narjust Florez and two esteemed oncology colleagues discuss an evolving hot topic: the use of immune checkpoint inhibitors in the treatment of patients with molecular driven non-small cell lung cancer. Guest: Dr. Erin Schenk is an Assistant Professor of Medicine in the section of Medical Oncology at the University of Colorado and the Director of the Schenk Laboratory X: @SchenkLab Guest: Dr. Biagio Ricciuti is a Thoracic Medical Oncologist and Data Scientist at Dana-Farber Cancer Institute and Harvard Medical School X: @BiagioRicciutMD